Related Experiment Video
Updated: Mar 23, 2026

06:09
Intratracheal Inoculation of Fischer 344 Rats with Francisella tularensis
Published on: September 30, 2017
7.6K
Progress, challenges, and opportunities in Francisella vaccine development.
Karen L Elkins1, Sherry L Kurtz1, Roberto De Pascalis1
1a Division of Bacterial, Parasitic, and Allergenic Products, CBER/FDA , Silver Spring , MD , USA.
Expert Review of Vaccines
|March 25, 2016
Summary
Understanding protective immunity against Francisella tularensis is advancing, with T cell-mediated immunity being crucial for vaccine success. Measuring T cell functions may help predict vaccine-induced protection in humans.
Area of Science:
- Immunology
- Vaccinology
- Microbial Pathogenesis
Background:
- Francisella tularensis pathogenesis and immunology are under renewed investigation.
- Understanding protective immunity is incomplete but crucial for developing effective vaccines.
- Animal models are advancing the study of Francisella tularensis.
Purpose of the Study:
- To review recent findings on protective immunity against Francisella tularensis.
- To highlight the role of T cell-mediated immunity in vaccination.
- To explore potential correlates of protection for vaccine development.
Main Methods:
- Review of current literature on Francisella tularensis immunology and vaccination.
- Analysis of data from animal models and human studies.
- Investigation of T cell functions and gene expression as potential correlates of protection.
Main Results:
- T cell-mediated immunity is critical for protection against Francisella tularensis.
- Specific antibodies and B cells play a supportive role in immunity.
- Measurements of T cell function and gene expression correlate with vaccine-induced protection in animal models.
Conclusions:
- Inducing T cell-mediated immunity is key for successful Francisella tularensis vaccination.
- Correlates of protection derived from T cell measurements could aid vaccine development.
- Further research is needed to translate findings from animal models to human applications.
Related Concept Videos
Vaccine Production
30
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
30
Vaccinations
53.5K
Overview
53.5K
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Vaccines
29
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
29

